logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine CAS

N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine CAS

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1421372-66-8

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
1421372-66-8
Appearance ::
Yellow Solid
Molecular Formula::
C25H31N7O
Molecular Weight::
445.56
EINECS NO::
N/A
MDL NO::
MFCD28167800
CAS NO::
1421372-66-8
Appearance ::
Yellow Solid
Molecular Formula::
C25H31N7O
Molecular Weight::
445.56
EINECS NO::
N/A
MDL NO::
MFCD28167800
N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine CAS

Product Description:

Product Name: N1-[2-(Dimethylamino)ethyl]-5-metho xy-N1-methyl-N4-[4-(1-methyl-1 H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine CAS NO: 1421372-66-8

 

 

 

 

 

 

Synonyms:

AZD9291 intermediate 3;

1,2,4-Benzenetriamine, N-[2-(dimethylamino)ethyl]-5-metho xy-N-methyl-N-[4-(1-methyl-1H -indol-3-yl)-2-pyrimidinyl]-;

N-[2-(Dimethylamino)ethyl]-5-metho xy-N-methyl-N-[4-(1-methyl-1H -indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine;

N1-[2-(diMethylaMino)ethyl]-5-Metho xy-N 1-Methyl-N4-[4-(1-Methyl-1H -indol-3-yl)-2-pyriMidinyl]benzene-1,2,4-triamine;;

 

 

 

 

 

Chemical & Physical Properties:

Appearance : Yellow Solid.

Assay : ≥99.0%

 

 

 

 

 

Mutated EGFR-IN-1 is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant and T790M resistance mutant.IC50 value:Target: Mutated EGFR inhibitorMore information can be found in Patent WO 2013014448 A1.2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer.

 

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.